Health Condition 1: C210- Malignant neoplasm of anus, unspecified
Conditions
Interventions
Intervention1: nil: nil
Control Intervention1: nil: nil
Sponsors
European Organisation for Research and Treatment of Cancer
Tata Memorial centre
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with a confirmed diagnosis of metastatic and/ or recurrent/persistent anal cancer managed by systemic treatment 2. Are aware of their diagnosis and treatment plan 3. Able to understand the language of the questioning 4. Aged 18 years or above 5. Receiving or having received treatment within the last 2 years 6. Patients who are willing and able to give fully informed consent to participate 7. No other diagnosed cancer
Exclusion criteria
Exclusion criteria: 1. Poor command of the English language 2. Patients under the age of 18 3. Diagnosis with other cancers within the last 5 years 4. Patients taking part in a clinical trial for non-approved drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Establish a preliminary item list of issues that are relevant to patients withmetastatic or recurrent/ persistent anal cancer. 2. Establish which of the items on the preliminary item list are already represented in the EORTC item library, or existing EORTC quality of life modules.Timepoint: 1. Establish a preliminary item list of issues that are relevant to patients withmetastatic or recurrent/ persistent anal cancer. 2. Establish which of the items on the preliminary item list are already represented in the EORTC item library, or existing EORTC quality of life modules. | — |
Secondary
| Measure | Time frame |
|---|---|
| NoneTimepoint: NA | — |
Countries
Austria, Belgium, United Kingdom
Contacts
Public ContactRahul Krishnatry
Tata Memorial Centre
Outcome results
None listed